DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Schreiber I, Buchfelder M, Droste M. et al.
Treatment of acromegaly with the GH receptor antagonist pegvisomant in clinical practice: Safety and efficacy evaluation from the German Pegvisomant Observational Study.
Eur J Endocrinol 2007;
156: 75-82
We do not assume any responsibility for the contents of the web pages of other providers.